DRDO issues directions on usage of anti-COVID drug 2-DG

The Defence Research and Development Organisation on Tuesday issued directions for use of 2DG medicine. It said the drug can be given to Covid-19 patients under the care and prescription of doctors as per DCGI approval.


The 2DG is approved for emergency use as adjunct therapy to the standard of care in the treatment of Covid patients in the hospital settings.

Caution should be exercised in patients with Uncontrolled diabetes, severe cardiac problem, severe hepatic and renal impairment ‬as the effect of this drug on these patients has not been studied yet.

It should not be given to pregnant and lactating women and patients below 18 years. Patients and attendants are advised to request their hospitals to contact Dr. Reddy’s Lab, Hyderbad for medicine supply.


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies